glp 1 agonists and sglt2 inhibitors combination Combining glucagon-like peptide-1 receptor (GLP-1RAs) sodium-glucose cotransporter-2 (SGLT2is) in patients with type 2 diabetes mellitus (T2DM) | Cardiovascular Diabetology GLP-1 Receptor Agonist Therapy With
Description
2010;123(5):468.e9468.e17
Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea
Subsequent administration of the GLP-1 receptor agonist semaglutide (Sem) to dams in late pregnancy revealed a modest decrease in maternal food intake during initial treatment
10.1038/s41467-022-32307-y
doi:10.3389/fendo.2019.00260 119
